231 related articles for article (PubMed ID: 36903413)
1. Discovering Hair Biomarkers of Alzheimer's Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics.
Su YH; Chang CW; Hsu JY; Li SW; Sung PS; Wang RH; Wu CH; Liao PC
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903413
[TBL] [Abstract][Full Text] [Related]
2. Identifying Hair Biomarker Candidates for Alzheimer's Disease Using Three High Resolution Mass Spectrometry-Based Untargeted Metabolomics Strategies.
Chang CW; Hsu JY; Hsiao PZ; Chen YC; Liao PC
J Am Soc Mass Spectrom; 2023 Apr; 34(4):550-561. PubMed ID: 36973238
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Hair Metabolome in 5xFAD Mice and Patients with Alzheimer's Disease Using Mass Spectrometry-Based Metabolomics.
Chang CW; Hsu JY; Lo YT; Liu YH; Mee-Inta O; Lee HT; Kuo YM; Liao PC
ACS Chem Neurosci; 2024 Feb; 15(3):527-538. PubMed ID: 38269400
[TBL] [Abstract][Full Text] [Related]
4. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples.
Milos T; Rojo D; Nedic Erjavec G; Konjevod M; Tudor L; Vuic B; Svob Strac D; Uzun S; Mimica N; Kozumplik O; Barbas C; Zarkovic N; Pivac N; Nikolac Perkovic M
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110830. PubMed ID: 37454721
[TBL] [Abstract][Full Text] [Related]
6. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
[TBL] [Abstract][Full Text] [Related]
9. Monitoring long-term chemical exposome by characterizing the hair metabolome using a high-resolution mass spectrometry-based suspect screening approach.
Chang CW; Hsu JY; Su YH; Chen YC; Hsiao PZ; Liao PC
Chemosphere; 2023 Aug; 332():138864. PubMed ID: 37156292
[TBL] [Abstract][Full Text] [Related]
10. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
[TBL] [Abstract][Full Text] [Related]
11. The identification of a potential plasma metabolite marker for Alzheimer's disease by LC-MS untargeted metabolomics.
Lin CH; Lin YN; Lane HY; Chen CJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1222():123686. PubMed ID: 37068461
[TBL] [Abstract][Full Text] [Related]
12. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
13. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
Hurtado MO; Kohler I; de Lange EC
Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
[TBL] [Abstract][Full Text] [Related]
14. Rat Hair Metabolomics Analysis Reveals Perturbations of Unsaturated Fatty Acid Biosynthesis, Phenylalanine, and Arachidonic Acid Metabolism Pathways Are Associated with Amyloid-β-Induced Cognitive Deficits.
Tan TH; Li SW; Chang CW; Chen YC; Liu YH; Ma JT; Chang CP; Liao PC
Mol Neurobiol; 2023 Aug; 60(8):4373-4395. PubMed ID: 37095368
[TBL] [Abstract][Full Text] [Related]
15. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
[TBL] [Abstract][Full Text] [Related]
16. Development of chemical isotope labeling LC-MS for tissue metabolomics and its application for brain and liver metabolome profiling in Alzheimer's disease mouse model.
Wang X; Han W; Yang J; Westaway D; Li L
Anal Chim Acta; 2019 Mar; 1050():95-104. PubMed ID: 30661596
[TBL] [Abstract][Full Text] [Related]
17. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
[TBL] [Abstract][Full Text] [Related]
18. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
19. Extraction strategies for tackling complete hair metabolome using LC-HRMS-based analysis.
Chang WC; Wang PH; Chang CW; Chen YC; Liao PC
Talanta; 2021 Feb; 223(Pt 1):121708. PubMed ID: 33303158
[TBL] [Abstract][Full Text] [Related]
20. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
